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The detection capability (CCβ) of some microbial screening tests (BRT MRL, Delvotest 26 
MCS SP-NT, Delvotest MCS Accelerator and Eclipse 100) currently available was 27 
calculated in accordance with Commission Decision 657/2002/EC. The CCβ was at or 28 
below the maximum residue limit (MRL) for most β-lactams assessed and other non-β-29 
lactam drugs such as neomycin, tylosin, sulfadiazine and sulfadimethoxine. However, 30 
the tests were less sensitive in the detection of most non-β-lactam drugs such as 31 
quinolones and tetracyclines at safety levels. When individual sheep milk samples free 32 
of antibiotics were analysed, an elevated somatic cell count (SCC) was related to the 33 
occurrence of non-compliant results in all the methods assessed. In order to guarantee 34 
the safety of milk and dairy products from small ruminants, the periodical 35 
implementation of screening tests more sensitive towards non-β-lactam drugs would be 36 
convenient. 37 
1. Introduction 38 
Microbial inhibitor tests are routinely applied for screening antibiotics in raw milk as 39 
they are relatively inexpensive, user-friendly, and have a high sample throughput. 40 
Most current microbial screening tests were initially developed to detect β-lactams in 41 
cow milk and are based on the inhibition of Geobacillus stearotermophilus var. 42 
calidolactis being highly sensitive to these substances. Several studies on the microbial 43 
test sensitivity using sheep milk have been carried out in the last two decades (Althaus, 44 
Torres, Montero, Balasch & Molina, 2003a; Molina, Althaus, Molina & Fernández, 45 
2003), while very few studies have been undertaken in goat milk (Sierra et al., 2009a,b), 46 
demonstrating that these tests are able to detect β-lactams at or below the Maximum 47 
Residue Limits (MRLs) established by European legislation (EC, 2010), but cannot 48 
suitably detect other veterinary drugs. 49 
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Therefore, modifications such as the addition of chelating agents into the culture 50 
medium to enhance the detection of tetracyclines, respectively, of antifolates to improve 51 
sulphonamide detection have been proposed (Langeveld, Beukers, Bommele, & Stark, 52 
2005), and consequently manufacturers have improved some performance 53 
characteristics of microbial screening tests in new versions now available. 54 
Moreover, sheep and goat milk is characterised by a higher fat and protein content than 55 
cow milk (Park, Juarez, Ramos & Haenlein, 2007), an elevated natural inhibitor content 56 
(e.g. immunoglobulins, lactoferrin, or lysozyme) (Crosson, Thomas, & Rossi, 2010) and 57 
a higher somatic cell count (SCC) even in the absence of intra-mammary infections 58 
(Medhid, Díaz, Martí, Vidal & Peris, 2013), potentially interfering in the microbial 59 
inhibitor test response. 60 
Sheep and goat milk production is mainly destined for the elaboration of dairy products. 61 
Antibiotic residues in milk may partially or totally inhibit fermentation processes in 62 
cheese and yogurt production (Packham, Broome, Limsowtin, & Roginski, 2001). 63 
Moreover, consumer safety may be compromised by the presence of these residues in 64 
dairy products (Oliver, Murinda & Jarayao, 2011). Thus, the aim of this study was to 65 
assess the performance of new versions of some microbial screening tests to detect 66 
antimicrobial residues in sheep and goat milk according to European Commission 67 
Decision nº 657/2002 (EC, 2002). 68 
2. Material and methods 69 
2.1. Microbial inhibitor tests: The screening tests used were the BRT MRL (Analytik in 70 
Milch Produktions-und Vertriebs-GmbH. Munich, Germany), Delvotest MCS SP-NT 71 
(DSM Food Specialties. Delft, the Netherlands), Delvotest MCS Accelerator (DSM 72 
Food Specialties), and Eclipse 100 (Zeu-Inmunotec. Zaragoza, Spain). All tests were 73 
conducted according to each manufacturer’s instructions.  74 
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2.2. Milk samples: Antibiotic-free milk samples were obtained from the experimental 75 
flocks of Manchega sheep of Universidad de Castilla-La Mancha (Albacete, Spain), and 76 
Murciano-Granadina goats of Universitat Politècnica de València (Valencia, Spain). 77 
Animals had a good health status and had not received any veterinary drugs, neither 78 
before nor during the experimental period, nor was medicated feed used in their diet. All 79 
milk samples were analysed for gross composition (MilkoScan 6000, Foss. Hillerd, 80 
Denmark), somatic cell count (Fossomatic 5000, Foss), total bacterial count (Bactoscan 81 
FC, Foss), and pH value (pHmeter, Crison, Barcelona, Spain). 82 
2.3. Antimicrobials and spiked milk samples: A total of 37 substances was investigated: 83 
amoxicillin, ampicillin, benzylpenicillin, cloxacillin, dicloxacillin, nafcillin, oxacillin, 84 
cefalonium, cefapirin, cefazolin, cefoperazone, cefquinome, ceftiofur, cephalexin, 85 
chlortetracycline, ciprofloxacin, colistin, enrofloxacin, erythromycin, gentamicin, 86 
lincomicin, marbofloxacin, neomycin, oxytetracycline, streptomycin, sulfadiazine, 87 
sulfadimethoxine, sulfametazine, tetracycline, trimethoprim, and tylosin were provided 88 
by Sigma-Aldrich Química, S.A. (Madrid, Spain). Desfuroylceftiofur was supplied by 89 
Toronto Research Chemicals, Inc. (Toronto, Canada) and the 4-epimers of tetracyclines 90 
were furnished by Acros Organics (Geel, Belgium). Finally, desacetylcefapirin and 91 
cefacetrile, not commercially available, were kindly provided by Fatro S.p.A. (Bologna, 92 
Italy) and ACS Dobfar, S.p.A. (Milan, Italy), respectively. Spiked milk samples were 93 
prepared following International Dairy Federation recommendations (ISO/IDF, 2003), 94 
and tested by the microbial screening tests immediately after spiking. 95 
2.4. Detection capability (CCβ): Test detection capability (CCβ) was investigated 96 
following the “Guidelines for the validation of screening methods for residues of 97 
veterinary medicines” proposed by Community Reference Laboratories for residues 98 
(CRLs, 2010), supplementing Commission Decision nº 657/2002 (EC, 2002). 99 
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Antimicrobial-free milk samples were spiked individually with different substances at 100 
0.5·MRL, 0.75·MRL, and 1·MRL equivalent drug concentration, and analysed 20, 40 or 101 
60 times, respectively, by the different microbial tests. 102 
2.5. Interferences related to milk matrix constituents: Antibiotic-free milk samples were 103 
obtained on a two-week basis along the entire milking period (sheep: n=250, sampling 104 
days 30 to 180 post-partum; goats: n=350, sampling days 15 to 200 post-partum) and 105 
analysed simultaneously, in three replicates, by the four tests. The effect of the milk 106 
matrix constituents on the test response was investigated using the stepwise option of 107 
the logistic procedure of the SAS software, according to the following model: 108 
Lij= logit [Pi] = β0 + β1[SL] + β2[pH] + β3[F] + β4[P] + β5[L] + β6[TS] + β7[logSCC] + 109 
β8[logBC] + εij (Eq. 1) 110 
where: Lij= logistic model; [Pi]= probability for the response category (positive/negative); 111 
β0= intercept; βi= estimate parameters for the model; [SL]= lactation stage effect (day); 112 
[pH]= pH effect; [F]= fat content effect; [P]= protein content effect; [L]= lactose content 113 
effect; [TS]= total solids content effect; [logSCC]= somatic cell count effect; [logBC]= 114 
bacterial count effect; εij= residual error. 115 
3. Results and discussion 116 
3.1. Detection capability (CCβ): The CCβ of the BRT MRL, Delvotest SP-NT, 117 
Delvotest DA, and Eclipse 100 tests in sheep and goat milk were shown in Table 1. In 118 
general, microbiological tests detected high frequencies of β-lactam antibiotics in milk 119 
from sheep (70.6 %: BRT MRL, and 88.2 %: Delvotest SP-NT, Delvotest DA, and 120 
Eclipse 100) and goats (76.4 %: BRT MRL, and 82.3 %: Delvotest SP-NT; Delvotest 121 
DA, and Eclipse 100). Only cefquinome and cefoperazone could not be detected by any 122 
test at MRL equivalent antibiotic concentration. 123 
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For non-β-lactam drugs, the microbiological tests could not detected residues of 124 
quinolones, tetracyclines, streptomycin, lincomicin, sulfametazine, colistin and 125 
trimethoprim at safety levels. Conversely, neomycin, tylosin sulfadiazine and 126 
sulfadimetoxine were detected at or below regulatory limits (Table 1). Moreover, the 127 
BRT MRL test was also able to detect gentamicin and erythromycin at their MRLs. 128 
3.2. Interferences related to the milk matrix effect  129 
Individual milk, free of antimicrobials, presented a wide range of variation for all milk 130 
quality parameters considered. When individual sheep milk samples were analysed an 131 
elevate percentage of non-compliant results were obtained (BRT MRL: 4.8 %, 132 
Delvotest SP-NT: 8.0 %, Delvotest DA: 10 % and Eclipse 100: 9.6 %). Applying 133 
logistic regression analysis, an increase in SCC was associated with an elevation in the 134 
predicted likelihood of positive outcomes in all cases (Figure 1), the BRT MRL test 135 
response being the less affected by this parameter. These results were in agreement with 136 
those obtained by Cullor et al. (1992) and Althaus et al. (2003b) using individual milk 137 
samples from cows and sheep, respectively. Instead, the percentage of non-compliant 138 
results in goat milk were lower in all cases (BRT MRL: 1.4 %, Delvotest SP-NT: 4.3 %, 139 
Delvotest DA: 3.1 % and Eclipse 100: 0.6 %), and therefore, logistic procedure was not 140 
performed. 141 
4. Conclusions 142 
Microbial inhibitor tests are efficient to detect β-lactams and other non-beta-lactam 143 
drugs such as neomycin, tylosin, sulfadiazine and sulfadimethoxine in raw milk from 144 
small ruminants. However, in spite of the improvements made in these tests in the last 145 
decade, they continue to be inefficient for the detection of other drugs, such as 146 
quinolones and tetracyclines, at safety levels. Therefore, the periodic use of more 147 
sensitive tests towards these substances would be convenient to widen the detection 148 
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range in screening and guarantee the quality of milk and dairy products from small 149 
ruminants. 150 
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Table 1. Detection capability (CCβ) of microbial screening tests for the detection of 
antimicrobials in sheep and goat milk. 
 
a
MRL: Maximum Residue Limit (µg·Kg
-1
) established by EC Regulation nº 37/2010 (EC, 2010); 
b
CCβ: 
Detection Capability (lower antimicrobial concentration which produces at least 95 % positive results); *: 




















β-lactams       
Amoxicillin 4 4/3 3/4 3/4 3/4 
Ampicillin 4 3/2 3/2 3/3 4/4 
Benzylpenicillin 4 3/2 3/2 3/2 4/2 
Cefacetrile 125 ≤63/≤63 ≤63/≤63 ≤63/≤63 ≤63/≤63 
Cefalonium 20 20/15 ≤10/15 20/15 20/15 
Cefapirin 60 ≤30/≤30 ≤30/≤30 ≤30/≤30 ≤30/≤30 
Deacetylcefapirin * ≤30/≤30 ≤30/≤30 ≤30/≤30 ≤30/≤30 
Cefazolin 50 ≤25/≤25 ≤25/≤25 ≤25/≤25 ≤25/≤25 
Cefoperazone 50 >50/>50 >50>50 >50/>50 >50/>50 
Cefquinome 20 >20/>20 >20/>20 >20/>20 >20/>20 
Ceftiofur 100 >100/>100 100/>100 100/>100 100/>100 
Desfuroylceftiofur * >100/100 75/100 100/100 100 
Cephalexin 100 >100/>100 ≤50/75 ≤50/≤50 ≤50/≤50 
Cloxacillin 30 23/23 ≤15/23 ≤15/23 23/23 
Dicloxacillin 30 ≤15/≤15 ≤15/≤15 ≤15/≤15 23/≤15 
Nafcillin 30 ≤15/≤15 ≤15/≤15 ≤15/≤15 ≤15/≤15 
Oxacillin 30 ≤15/≤15 ≤15/≤15 ≤15/≤15 ≤15/≤15 
Aminoglycosides      
Gentamicin 100 100/100 >100/>100 >100/>100 >100/>100 
Neomycin 1,500 ≤750/≤750 ≤750/≤750 ≤750/≤750 >1,500/>1,500 
Streptomycin 200 >200/>200 >200/>200 >200/>200 >200/>200 
Macrolides      
Erythromycin 40 40/40 >40/>40 >40/>40 >40/>40 
Lincomicin 150 >150/>150 >150/>150 >150/>150 >150/>150 
Tylosin 50 ≤25/50 ≤25/≤25 ≤25/50 ≤25/50 
Sulphonamides      
Sulfadiazine 100 >100/>100 75/≤50 75/75 75/≤50 
Sulfadimethoxine 100 ≤50/≤50 ≤50/≤50 75/≤50 100/100 
Sulfametazine 100 >100/>100 >100/>100 >100/>100 >100/>100 
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Figure 1. Effect of the somatic cell count (SCC) on the false non-compliant outcomes of 
microbial screening tests using sheep milk. 
 
 
